Rx for the pharmaceutical industry: Call your doctors

Hastings Center Report

Volumn 39, Issue 4, 2009, Pages 18-21

  Kitsis, Elizabeth A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG RESEARCH; ETHICAL DECISION MAKING; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MEDICAL RESEARCH; SHORT SURVEY; ARTICLE; COMMERCIAL PHENOMENA; ETHICS; PHYSICIAN ATTITUDE; UNITED STATES;

COMMERCE; DRUG INDUSTRY; PHYSICIAN'S ROLE; UNITED STATES;

EID: 70349577147     PISSN: 00930334     EISSN: 1552146X     Source Type: Journal    
DOI: 10.1353/hcr.0.0160     Document Type: Short Survey

References (25)

1. D. Healy, "The Latest Mania: Selling Bipolar Disorder", PLoS Medicine 3(2006):441-43.
2. K. P. Hill et al., "The ADVANTAGE Seeding Trial: A Review of Internal Documents", Annals of Internal Medicine 149(2008):251-58.
3. A. Berenson, "Drug Files Show Maker Promoted Unapproved Use", New York Times, December 18, 2006.
4. Scandinavian Simvastatin Survival Study Group, "Randomized Trial of Cholesterol Lowering in 4444 Patients with Coronary Heart Disease: The Scandinavian Simvastatin Survival Study (4S), "" Lancet 344(1994):1383-89.
5. J. M. Bathon et al., "A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis", New England Journal of Medicine 343(2000):1586-93.
6. B. J. Druker et al., "Five-Year Follow-Up of Patients Receiving Imatinib for Chronic Myeloid Leukemia", New England Journal of Medicine 355(2006):2408-2417.
7. Pharmaceutical Research and Manufacturers of America (PhRMA), Pharmaceutical Industry Profile (Washington, D. C.: PhRMA, 2009).
8. D. A. Zarin and T. Tse, "Medicine: Moving Toward Transparency of Clinical Trials", Science 319, no. 5968(2008):1340-42.
9. S. H. Ehringhaus et al., "Responses of Medical Schools to Institutional Conflicts of Interest", Journal of the American Medical Association 299(2008):665-71.
10. C. D. DeAngelis et al., "Clinical Trial Registration: A Statement from the International Committee of Medical Journal Editors", Journal of the American Medical Association 292(2004):1363-64.
11. J. E. Mackie et al., "Lessons on Ethical Decision Making from the Bioscience Industry", PLoS Medicine 3, no. 5(2006):605-610.
12. Roche, "Ethical Standards", at http://www.roche.com/corporate- responsibility/csr-research-and-development/ethical-standards.htm, accessed April 29, 2009.
13. Merck, "Conducting Ourselves Ethically and Transparently", at http://www.merck.com/corporate-responsibility/business-ethics-transparency/ priorities-targets-sidebar.html, accessed April 29, 2009;
14. Abbott, "Ethics and Compliance", at http://www.abbott.com/ global/url/content/en-US/40.60.10:10/general-content-00258.htm, accessed April 29, 2009.
15. Ibid.; GlaxoSmithKline, "Corporate Ethics and Compliance Programme", http://www.gsk.com/about/corp-gov-ethics.htm, accessed April 29, 2009;
16. Eli Lilly and Company, "Code of Conduct", at http://www.lilly.com/about/compliance/conduct/, accessed April 29, 2009.
17. PhRMA, Pharmaceutical Industry Profile.
18. P. B. Miller and C. Weijer, "Fiduciary Obligation in Clinical Research", Journal of Law, Medicine and Ethics 34, no. 2(2006):424-440.
19. E. D. Pellegrino, "Beneficence, Scientific Autonomy, and Self-Interest: Ethical Dilemmas in Clinical Research", Cambridge Quarterly of Healthcare Ethics 1(1992):361-69.
20. D. R. Buchanan and F. G. Miller, "A Public Health Perspective on Research Ethics", Journal of Medical Ethics 32(2006):729-33.
21. Pellegrino, "Beneficence, Scientific Autonomy, and Self-Interest. "
22. U. S. Department of Health and Human Services, "Frequently Asked Questions for the Requirement for Education on the Protection of Human Subjects", at http://grants.nih.gov/policy/hs-educ-faq.htm, accessed April 29, 2009.
23. American Board of Medical Specialties, "Our History", at http://www.abms.org/About-ABMS/who-we-are.aspx, accessed May 5, 2009.
24. H. S. James, "Reinforcing Ethical Decision Making Through Organizational Structure", Journal of Business Ethics 28(2000):43-58.
25. E. H. Schein, Organizational Culture and Leadership (San Francisco, Calif.: Jossey-Bass, 2004).